Pronunciation: [dˈiːsˈɪs] (IPA) 
DCIS stands for Ductal Carcinoma In Situ, a type of breast cancer. The spelling of this word can be explained using IPA phonetic transcription. "D" is pronounced as [d], "C" is pronounced as [s], "I" as [ɪ], and "S" as [s]. Thus, when pronounced together, DCIS is pronounced as ["di si aɪ es"]. It is essential to spell medical terms correctly to avoid confusion and ensure accurate communication between healthcare professionals and patients.
DCIS, acronym for Ductal Carcinoma In Situ, is a medical term typically used in the field of oncology to describe a type of breast cancer that starts in the milk ducts and is confined within the breast ductal system without infiltrating the surrounding tissue. It is considered an early-stage, non-invasive form of breast cancer.
Ductal Carcinoma In Situ is characterized by abnormal cells that are present within the milk ducts of the breast. The term "in situ" refers to the fact that these cancer cells are localized and have not spread beyond the ducts into nearby breast tissue or other areas of the body. DCIS is usually detected through a mammogram or during a biopsy and is often a non-palpable condition, meaning that it cannot be felt through a breast exam.
Although DCIS is classified as non-invasive, if left untreated, it has the potential to progress or become invasive, where the cancer cells can spread beyond the milk ducts and invade the surrounding breast tissue. Therefore, early detection and appropriate treatment of DCIS are crucial in preventing its progression.
Treatment options for DCIS usually include surgical removal of the affected tissue through lumpectomy (removal of the tumor and some surrounding tissue) or mastectomy (removal of the entire breast). Additional treatments, such as radiation therapy or hormone therapy, may also be recommended depending on the individual case. Regular follow-up care and monitoring are important to detect any potential recurrence or development of invasive breast cancer.
